Early Recognition and Timely Diagnosis of Malignant Melanoma – IHCRI-Rwanda
IHCRI-Rwanda/X

Early Recognition and Timely Diagnosis of Malignant Melanoma – IHCRI-Rwanda

IHCRI-Rwanda (Internal Health Cancer and Research Initiative Rwanda) shared a post on LinkedIn:

“We did it!

Our latest Cancer Webinar Series session on Malignant Melanoma is now available to watch – and it was packed with insights you don’t want to miss.

Theme: Malignant Melanoma: Bridging Awareness, Diagnosis and Treatment

Our expert speakers brought clarity, depth, and urgency to one of the most aggressive forms of skin cancer:

  • Malignant melanoma affects people of All skin types – not just fair-skinned individuals. Awareness across diverse populations is critical.
  • Early recognition is everything. Changes in the size, shape, color, or appearance of a skin lesion should Never be ignored.
  • Timely diagnosis dramatically improves survival outcomes. The window between suspicion and biopsy matters.
  • Healthcare professionals must maintain a High index of suspicion and strengthen multidisciplinary collaboration — from dermatology to pathology.
  • Public education, routine skin examinations, and prompt medical consultation are the pillars of early detection.

A huge thank you to our incredible speakers:

  • Dr. Thomas Habanabakize – Consultant Anatomical Pathologist, King Faisal Hospital Rwanda (Dr.Thomas HABANABAKIZE, MD, MMed)
  • Dr. Lyon Chipandwe – Consultant Dermatologist, CEO of Zambulance Health Services and Lyon Aesthetics Lyon chipandwe,
  • Miti Senkwe Elizabeth – Moderator

And to our partners at UNZAMEDSA for bringing together students, clinicians, researchers, and advocates across Africa.

Together, we are building a generation of healthcare professionals who detect cancer earlier, treat it better, and advocate louder.

Organized by: IHCRI-Rwanda (Internal Health, Cancer and Research Initiative)
In collaboration with: University of Zambia Medical Students Association (UNZAMEDSA).

Watch the video

Other articles on OncoDaily.